These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 37148431)
1. Neurometabolic changes in a rat pup model of type C hepatic encephalopathy depend on age at liver disease onset. Simicic D; Rackayova V; Braissant O; Toso C; Oldani G; Sessa D; McLin VA; Cudalbu C Metab Brain Dis; 2023 Aug; 38(6):1999-2012. PubMed ID: 37148431 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy. Braissant O; Rackayová V; Pierzchala K; Grosse J; McLin VA; Cudalbu C J Hepatol; 2019 Sep; 71(3):505-515. PubMed ID: 31173812 [TBL] [Abstract][Full Text] [Related]
4. Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. Bosoi CR; Zwingmann C; Marin H; Parent-Robitaille C; Huynh J; Tremblay M; Rose CF J Hepatol; 2014 Mar; 60(3):554-60. PubMed ID: 24512824 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal osmotic and neurometabolic changes in young rats with chronic cholestatic liver disease. Rackayova V; Braissant O; Rougemont AL; Cudalbu C; McLin VA Sci Rep; 2020 May; 10(1):7536. PubMed ID: 32372057 [TBL] [Abstract][Full Text] [Related]
6. Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease. Rackayová V; Flatt E; Braissant O; Grosse J; Capobianco D; Mastromarino P; McMillin M; DeMorrow S; McLin VA; Cudalbu C Sci Rep; 2021 Jan; 11(1):2269. PubMed ID: 33500487 [TBL] [Abstract][Full Text] [Related]
8. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure. Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634 [TBL] [Abstract][Full Text] [Related]
9. High field brain proton magnetic resonance spectroscopy and volumetry in children with chronic, compensated liver disease - A pilot study. Cudalbu C; Xin L; Marechal B; Lachat S; Zangas-Gheri F; Valenza N; Hanquinet S; McLin VA Anal Biochem; 2023 Aug; 675():115212. PubMed ID: 37356555 [TBL] [Abstract][Full Text] [Related]
10. Diffusion of brain metabolites highlights altered brain microstructure in type C hepatic encephalopathy: a 9.4 T preliminary study. Mosso J; Briand G; Pierzchala K; Simicic D; Sierra A; Abdollahzadeh A; Jelescu IO; Cudalbu C Front Neurosci; 2024; 18():1344076. PubMed ID: 38572151 [TBL] [Abstract][Full Text] [Related]
11. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. Ahluwalia V; Wade JB; Thacker L; Kraft KA; Sterling RK; Stravitz RT; Fuchs M; Bouneva I; Puri P; Luketic V; Sanyal AJ; Gilles H; Heuman DM; Bajaj JS J Hepatol; 2013 Sep; 59(3):467-73. PubMed ID: 23665182 [TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551 [TBL] [Abstract][Full Text] [Related]
13. Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE. Flatt E; McLin VA; Braissant O; Pierzchala K; Mastromarino P; Mitrea SO; Sessa D; Gruetter R; Cudalbu C Sci Rep; 2021 Sep; 11(1):17988. PubMed ID: 34504135 [TBL] [Abstract][Full Text] [Related]
14. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis. Srivastava A; Chaturvedi S; Gupta RK; Malik R; Mathias A; Jagannathan NR; Jain S; Pandey CM; Yachha SK; Rathore RKS J Hepatol; 2017 Mar; 66(3):528-536. PubMed ID: 27815224 [TBL] [Abstract][Full Text] [Related]
15. Abnormal brain oxygen homeostasis in an animal model of liver disease. Hadjihambi A; Cudalbu C; Pierzchala K; Simicic D; Donnelly C; Konstantinou C; Davies N; Habtesion A; Gourine AV; Jalan R; Hosford PS JHEP Rep; 2022 Aug; 4(8):100509. PubMed ID: 35865351 [TBL] [Abstract][Full Text] [Related]
16. Sex is associated with differences in oxidative stress and susceptibility to severe hepatic encephalopathy in bile-duct ligated rats. Macedo de Oliveira M; Monnet-Aimard A; Bosoi CR; Tremblay M; Rose CF J Neurochem; 2022 Aug; 162(4):337-351. PubMed ID: 35771118 [TBL] [Abstract][Full Text] [Related]
17. A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation. Claeys W; Van Hoecke L; Geerts A; Van Vlierberghe H; Lefere S; Van Imschoot G; Van Wonterghem E; Ghesquière B; Vandenbroucke RE; Van Steenkiste C Sci Rep; 2022 Oct; 12(1):17558. PubMed ID: 36266427 [TBL] [Abstract][Full Text] [Related]
18. In vivo proton magnetic resonance spectroscopy for the evaluation of hepatic encephalopathy in dogs. Carrera I; Kircher PR; Meier D; Richter H; Beckman K; Dennler M Am J Vet Res; 2014 Sep; 75(9):818-27. PubMed ID: 25157885 [TBL] [Abstract][Full Text] [Related]
19. What the clinician can learn from MR glutamine/glutamate assays. Chamuleau RA; Bosman DK; Bovée WM; Luyten PR; den Hollander JA NMR Biomed; 1991 Apr; 4(2):103-8. PubMed ID: 1677585 [TBL] [Abstract][Full Text] [Related]